Donald Trump’s remarks come on the heels of a sweeping set of tariffs he imposed earlier this month on imports from countries ...

Even before President Trump's announcement that he plans a "major tariff" on pharmaceuticals, the sector was getting hammered ...

The US giants which supply vital new medicines to UK patients face disruption from Donald Trump’s trade barriers, experts warn ...

The $1.7 trillion revenue prescription drug industry has a relatively robust immunity to tariffs. Last Wednesday, when U.S.

Trump predicted a tariff on foreign pharmaceuticals will prompt drug companies to move their operations to the United States.

European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite ...

Although President Donald Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import taxes ...

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...

Calley Means is advising Kennedy's overhaul of HHS and he doesn't hesitate to lambaste the people he says are profiting from a broken health care system that keeps people sick.

This is CNBC’s coverage of how U.S. trade partners, industries and employers respond to President Donald Trump’s historic tariffs.

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.